알레르기성 호흡기 질환에서의 항원특이면역요법

키워드

참고문헌 (40)

1. Calderón MA, "Validation of patient-reported outcomes for clinical trials in allergic rhinitis : a systematic review", J Allergy Clin Immunol Pract, 7, pp.1450~1461 (2019)[DOI]
2. Calderon MA, "Allergen injection immunotherapy for seasonal allergic rhinitis", Cochrane Database Syst Rev, 2007, pp.001936~ (2007)
3. Radulovic S, "Sublingual immunotherapy for allergic rhinitis", Cochrane Database Syst Rev, (12), pp.CD002893~ (2010)
4. Durham SR, "Sublingual or subcutaneous immunotherapy for allergic rhinitis?", J Allergy Clin Immunol, 137, pp.339~349 (2016)[DOI]
5. Domdey A, "Allergy immunotherapies for allergic rhinitis : systematic review and assessment of evolving quality", Eur Ann Allergy Clin Immunol, 51, pp.147~158 (2019)
6. Kim ST, "Allergen-specific intralymphatic immunotherapy in human and animal studies", Asia Pac Allergy, 7, pp.131~137 (2017)
7. 강성윤, "임파선내항원특이면역요법", Allergy Asthma & Respiratory Disease, 8(2), pp.53~65 (2020), 대한 소아알레르기 호흡기학회[DOI]
8. Esposito S, "Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies : a review of the literature", J Transl Med, 16, pp.329~ (2018)
9. Abramson MJ, "Injection allergen immunotherapy for asthma", Cochrane Database Syst Rev (2010)
10. Mosbech H, "Standardized quality(SQ)house dust mite sublingual immunotherapy tablet(ALK)reduces inhaled corticosteroid use while maintaining asthma control : a randomized, double-blind, placebo-controlled trial", J Allergy Clin Immunol, 134, pp.568~575 (2014)[DOI]
11. Virchow JC, "Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma : a randomized clinical trial", JAMA, 315, pp.1715~1725 (2016)
12. "Global strategy for asthma management and prevention" (2020)[URL]
13. Liu Z, "Predictive methods for efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients : a prospective study in a Chinese population", Int Forum Allergy Rhinol, 10, pp.314~319 (2020)
14. Fujita H, "Mechanisms of allergen-specific immunotherapy", Clin Transl Allergy, 2, pp.2~ (2012)
15. van de Veen W, "Tolerance mechanisms of allergen immunotherapy", Allergy, 75, pp.1017~1018 (2020)
16. 이상표, "A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies", Allergy, Asthma & Immunology Research, 9(3), pp.272~277 (2017), 대한천식알레르기학회
17. Son JY, "Changes in skin reactivity and associated factors in patients sensitized to house dust mites after 1 year of allergen-specific immunotherapy", Asia Pac Allergy, 7, pp.82~91 (2017)
18. Graf N, "A critical appraisal of analyzing nasal provocation test results in allergen immunotherapy trials", Rhinology, 52, pp.137~141 (2014)
19. Tenn MW, "Nasal challenges in allergen immunotherapy trials", Curr Opin Allergy Clin Immunol, 18, pp.489~494 (2018)
20. Wintersand A, "Allergens in dog extracts : implication for diagnosis and treatment", Allergy, 74, pp.1472~1479 (2019)
21. Chan SK, "Dog and cat allergies : current state of diagnostic approaches and challenges", Allergy Asthma Immunol Res, 10, pp.97~105 (2018)
22. 양민석, "Dog and Cat Allergies and Allergen Avoidance Measures in Korean Adult Pet Owners Who Participated in a Pet Exhibition", Allergy, Asthma & Immunology Research, 10(2), pp.155~164 (2018), 대한천식알레르기학회
23. Polosa R, "Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis", Allergy, 59, pp.1224~1228 (2004)
24. Jacobsen L, "Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma : 10-year follow-up on the PAT study", Allergy, 62, pp.943~948 (2007)
25. Schmid JM, "Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract", J Allergy Clin Immunol, 137, pp.562~570 (2016)
26. Di Lorenzo G, "Evaluation of serum s-IgE", total IgE ratio in predicting clinical response to allergen-specific immunotherapy, 2009, pp.123, 1103~1110
27. Berings M, "FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy", Clin Exp Allergy, 48, pp.970~980 (2018)
28. Fujimura T, "Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy(SLIT)for Japanese cedar pollinosis", Clin Immunol, 139, pp.65~74 (2011)
29. Huang Y, "Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients", Clin Transl Allergy, 9, pp.64~ (2019)
30. Shamji MH, "Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy", Allergy, 67, pp.217~226 (2012)
31. Zhao D, "The functional IgE-blocking factor induced by allergen-specific immunotherapy correlates with IgG4 antibodies and a decrease of symptoms in house dust mite-allergic children", Int Arch Allergy Immunol, 169, pp.113~120 (2016)
32. Feng M, "Functional and immunoreactive levels of IgG4 correlate with clinical responses during the maintenance phase of house dust mite immunotherapy", J Immunol, 200, pp.3897~3904 (2018)
33. Salmani A, "A significant increase in expression of FOXP3 and IL-17 genes in patients with allergic rhinitis underwent accelerated rush immunotherapy", Iran J Basic Med Sci, 22, pp.989~996 (2019)
34. Xian M, "Changes in CD4+CD25+FoxP3+ regulatory T cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without asthma", Int Arch Allergy Immunol, 181, pp.71~80 (2020)
35. Lü FX, "Novel nasal secretion collection method for the analysis of allergen specific antibodies and inflammatory biomarkers", J Immunol Methods, 356, pp.6~17 (2010)
36. Gueguen C, "Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy", J Allergy Clin Immunol, 137, pp.545~558 (2016)
37. Schmid JM, "Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy", J Allergy Clin Immunol, 134, pp.741~744 (2014)[DOI]
38. Shamji MH, "Basophil expression of diamine oxidase : a novel biomarker of allergen immunotherapy response", J Allergy Clin Immunol, 135, pp.913~921 (2015)[DOI]
39. Caruso M, "Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis", Int Immunopharmacol, 60, pp.50~58 (2018)
40. Fujimura T, "The induced regulatory T cell level, defined as the proportion of IL-10(+)Foxp3(+)cells among CD25(+)CD4(+)leukocytes, is a potential therapeutic biomarker for sublingual immunotherapy : a preliminary report", Int Arch Allergy Immunol, 153, pp.378~387 (2010)

관련 논문AI추천